文献速递心律失常心力衰竭与心肌病

家族研究提示致心律失常性右室心肌病存在自身免疫:抗心肌与抗闰盘自身抗体与疾病严重程度及家族史相关

Evidence From Family Studies for Autoimmunity in Arrhythmogenic Right Ventricular Cardiomyopathy: Associations of Circulating Anti-Heart and Anti-Intercalated Disk Autoantibodies With Disease Severity and Family History.
PubMed 文献 · Circulation · 2020-03-02

研究在42例ARVC先证者、37例临床受累亲属及96例健康亲属中检测抗心肌抗体(AHA)和抗闰盘抗体(AIDA),并与非炎症性心脏病、缺血性心衰及健康献血者对照。AHA和AIDA在ARVC家系中频率显著升高,且抗体阳性与心悸、ICD植入、左室射血分数降低及家族性家系相关。结论提示多数家族性和近半数散发性ARVC存在自身免疫证据。

要点

  • ARVC先证者及受累亲属AHA阳性率约37%,健康亲属25%,显著高于疾病和健康对照。
  • AIDA在受累亲属阳性率21.6%,健康亲属14.6%,均显著高于对照组。
  • AHA阳性与心悸、ICD植入及较低左室射血分数相关,AIDA阳性与双心室射血分数降低相关。

核心结论

  • AHA和AIDA的存在为多数家族性和近半数散发性ARVC提供了自身免疫证据。
  • 在先证者和临床受累亲属中,这些自身抗体与疾病严重程度特征相关。

研究设计与样本

  • 研究纳入42例ARVC先证者(男23例,年龄42岁,IQR 33-49;家族性20例,非家族性22例)、37例临床受累亲属(男24例,年龄35岁,IQR 18-46)和96例健康亲属(男49例,年龄27岁,IQR 17-45)。
  • 对175例ARVC个体中的171例及对照(非炎症性心脏病160例、缺血性心衰141例、健康献血者270例)用间接免疫荧光法检测血清AHA和AIDA。
  • 对先证者行5个桥粒基因筛查,发现序列变异后行家系 cascade 筛查,免疫学结果设盲。

主要发现

  • AHA频率在先证者36.8%、受累亲属37.8%、健康亲属25%,高于非炎症性心脏病1%、缺血性心衰1%、健康献血者2.5%(P=0.0001)。
  • AIDA频率在先证者8%(P=0.006)、受累亲属21.6%(P=0.00001)、健康亲属14.6%(P=0.00001),高于非炎症性心脏病3.75%、缺血性心衰2%、健康献血者0.3%。
  • AHA阳性与较高心悸频率(P=0.004)、ICD植入(P=0.021)、较低左室射血分数(P=0.004)相关;AIDA阳性与较低右室和左室射血分数相关(P=0.027和P=0.027)。
  • 先证者及至少一名相应亲属AHA和/或AIDA阳性在家族性家系中更常见(17/20,85%),高于散发性家系(10/22,45%;P=0.007)。

临床怎么用

  • 在ARVC家系评估中,可考虑检测AHA和AIDA以辅助识别自身免疫参与及疾病严重程度较高的个体。
  • 抗体阳性与更差的心室功能和ICD植入相关,提示对阳性患者加强心功能与心律失常监测。

局限性

  • 需要纵向研究明确这些抗体是否能预测健康亲属发生ARVC,或仅是显性ARVC的结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Serum anti-heart autoantibodies (AHAs) and anti-intercalated disk autoantibodies (AIDAs) are autoimmune markers in myocarditis. Myocarditis has been reported in arrhythmogenic right ventricular cardiomyopathy (ARVC). To provide evidence for autoimmunity, we searched for AHAs and AIDAs in ARVC. METHODS: We studied: 42 ARVC probands, 23 male, aged 42, interquartile range 33-49, 20 from familial and 22 nonfamilial pedigrees; 37 clinically affected relatives (ARs), 24 male aged 35, interquartile range 18-46; and 96 healthy relatives, 49 male, aged 27, interquartile range 17-45. Serum AHAs and AIDAs were tested by indirect immunofluorescence on human myocardium and skeletal muscle in 171 of the 175 ARVC individuals and in controls with noninflammatory cardiac disease (n=160), ischemic heart failure (n=141), and healthy blood donors (n=270). Screening of 5 desmosomal genes was performed in probands; when a sequence variant was identified, cascade family screening followed, blind to immunologic results. RESULTS: AHA frequency was higher (36.8%) in probands, ARs (37.8%), and healthy relatives (25%) than in noninflammatory cardiac disease (1%), ischemic heart failure (1%), or healthy blood donors (2.5%; P=0.0001). AIDA frequency was higher in probands (8%, P=0.006), in ARs (21.6%, P=0.00001), and in healthy relatives (14.6%, P=0.00001) than in noninflammatory cardiac disease (3.75%), ischemic heart failure (2%), or healthy blood donors (0.3%). AHA-positive status was associated with higher frequency of palpitation (P=0.004), implantable cardioverter defibrillator implantation (P=0.021), lower left ventricular ejection fraction (P=0.004), AIDA-positive status with both lower right ventricular and left ventricular ejection fractions (P=0.027 and P=0.027, respectively). AHA- and/or AIDA-positive status in the proband and at least one of the respective relatives was more common in familial (17/20, 85%) than in sporadic (10/22, 45%) pedigrees (P=0.007). CONCLUSIONS: The presence of AHAs and AIDAs provides evidence of autoimmunity in the majority of familial and in almost half of sporadic ARVC. In probands and in ARs, these antibodies were associated with features of disease severity. Longitudinal studies are needed to clarify whether they may predict ARVC development in healthy relatives or if they be a result of manifest ARVC.

来源:Circulation,查看原文。版权归原作者所有。

引用

  1. Caforio ALP, Re F, Avella A, et al. Evidence From Family Studies for Autoimmunity in Arrhythmogenic Right Ventricular Cardiomyopathy: Associations of Circulating Anti-Heart and Anti-Intercalated Disk Autoantibodies With Disease Severity and Family History. Circulation. 2020. PMID: 32114801. doi:10.1161/CIRCULATIONAHA.119.043931

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。